Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lurasidone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102952001A offers cost-effective chiral intermediate production. Enhances supply chain reliability for Lurasidone manufacturing.
Novel one-pot synthesis for Lurasidone intermediates reduces costs and improves purity. Ideal for reliable pharmaceutical intermediates supplier partnerships globally.
Patent CN104513182A details a safer synthetic route for Lurasidone intermediates offering enhanced supply chain stability and reduced toxic waste for global pharmaceutical manufacturers.
Patent CN102746289B reveals a robust crystallization process for Lurasidone Hydrochloride, ensuring high purity and low solvent residue for cost reduction in pharmaceutical manufacturing.
Patent CN107936007A details a water-catalyzed synthesis for lurasidone hydrochloride offering cost reduction and supply chain reliability for pharmaceutical intermediates.